The difference between positive and negative blood types comes down to a single protein on the surface of your red blood cells. If your red blood cells carry a protein called the Rh factor (specifically the D antigen), your blood type is positive. If they don’t, it’s negative. That’s the “+” or “−” after the letter in your blood type, like A+ or O−.
This small distinction has major implications for blood transfusions, pregnancy, and emergency medicine. Here’s what it actually means for your body and your health.
What the Rh Factor Actually Is
Your blood type has two parts. The letter (A, B, AB, or O) refers to one set of markers on your red blood cells. The positive or negative label refers to a completely separate marker: the Rh factor. Together, these create the eight common blood types: A+, A−, B+, B−, AB+, AB−, O+, and O−.
The Rh factor is a protein embedded in the membrane of your red blood cells. It sits within the cell wall itself, spanning back and forth across the membrane 12 times. It’s part of a larger protein complex that likely plays a role in transporting molecules across cell membranes, though scientists still don’t fully understand its original biological purpose. What matters for medicine is simpler: your immune system either recognizes this protein as “self” or treats it as a foreign invader.
How You Inherit Your Blood Type
You get one Rh gene from each parent. The positive version is dominant, meaning it overrides the negative version. So there are three possible gene combinations:
- Two positive genes (+ +): Your blood type is positive.
- One positive, one negative (+ −): Your blood type is still positive, but you carry the negative gene and can pass it to your children.
- Two negative genes (− −): Your blood type is negative. This is the only combination that produces a negative blood type.
This is why two Rh-positive parents can have an Rh-negative child. If both parents carry a hidden negative gene (+ −), there’s a one-in-four chance their baby inherits the negative gene from both sides and ends up − −. It also means two Rh-negative parents will always have Rh-negative children, since neither parent has a positive gene to pass on.
How Common Each Type Is
Rh-positive blood is far more common. Roughly 85 to 92% of the global population is Rh-positive, depending on ethnicity and geographic region. Only about 7 to 15% of people are Rh-negative. In the United States, about 37% of the population has O-positive blood, the most common type, while only about 7% is O-negative.
Rh-negative blood types are most common among people of European descent and less common in Asian, African, and Middle Eastern populations. Even within the same country, rates can vary between ethnic groups by several percentage points.
Why It Matters for Transfusions
If you’re Rh-negative and receive Rh-positive blood, your immune system may recognize the Rh protein as foreign and build antibodies against it. Those antibodies can then attack Rh-positive blood cells in any future transfusion, causing a potentially dangerous reaction. For this reason, Rh-negative patients receive Rh-negative blood.
Rh-positive patients, on the other hand, can safely receive either Rh-positive or Rh-negative blood. Their immune system already recognizes the Rh protein, so the absence of it on donated cells doesn’t trigger a problem.
This is why O-negative blood is used in emergencies when there’s no time to check a patient’s blood type. It lacks both the A/B markers and the Rh factor, so it won’t trigger an immune reaction in virtually anyone. But O-negative donors make up only about 7% of the population, creating a constant supply challenge. In trauma situations where O-negative supplies run low, hospitals sometimes use O-positive blood instead. Studies show that only a portion of Rh-negative patients who receive Rh-positive red cells actually develop antibodies, so the risk is weighed against the immediate need to save a life. Women of childbearing age are preferentially given O-negative blood in emergencies because of the additional pregnancy risks.
The Biggest Risk: Rh Incompatibility in Pregnancy
The most significant medical consequence of being Rh-negative involves pregnancy. If an Rh-negative mother carries an Rh-positive baby, and some of the baby’s blood crosses into her bloodstream, her immune system can start producing antibodies against the Rh protein. This process is called sensitization.
During a normal pregnancy, mother and fetus don’t usually share blood directly. But small amounts of fetal blood can enter the mother’s circulation during labor and delivery, during procedures like amniocentesis, after abdominal trauma, during a miscarriage, or during an ectopic pregnancy. Once the mother’s immune system has been sensitized, it remembers. In a future pregnancy with another Rh-positive baby, those antibodies can cross the placenta and attack the baby’s red blood cells.
This typically doesn’t cause problems in a first pregnancy because the mother’s body hasn’t built up enough antibodies yet. The danger comes with subsequent pregnancies. The antibodies destroy the baby’s red blood cells faster than the baby can replace them, leading to severe anemia. Without enough red blood cells, the baby doesn’t get adequate oxygen. This condition, called hemolytic disease of the newborn, can cause jaundice, dangerous fluid buildup throughout the baby’s body, and in the most severe cases, heart failure or death.
How It’s Prevented
A preventive injection given to Rh-negative mothers stops sensitization before it starts. This injection contains antibodies that find and destroy any Rh-positive fetal cells in the mother’s bloodstream before her immune system notices them. The standard protocol calls for one injection around 26 to 28 weeks of pregnancy and another within 72 hours after delivery if the baby turns out to be Rh-positive. Additional doses are given after any event that could cause fetal blood to mix with the mother’s, such as amniocentesis, significant bleeding, or pregnancy loss after 12 weeks. This treatment has made severe Rh disease rare in countries where it’s routinely available.
The Rarest Blood Type of All
Beyond the standard positive and negative categories, there’s an extremely rare condition called Rh-null, sometimes nicknamed “golden blood.” People with this phenotype lack all Rh antigens on their red blood cells, not just the D antigen that determines positive or negative status. Fewer than 1 in 6 million people have it.
Rh-null blood can be donated to anyone who is Rh-negative, making it extraordinarily valuable for transfusions. But it comes with a cost for the people who have it. Without any Rh proteins, their red blood cells are structurally fragile. The cells become misshapen, break down more easily, and leak ions abnormally. This leads to chronic low-grade anemia that varies in severity from person to person. People with Rh-null blood also face a serious practical problem: if they ever need a transfusion themselves, only blood from another Rh-null donor will work. With so few people carrying this phenotype worldwide, finding a match can be nearly impossible.
What Your Rh Status Means for You
If you’re Rh-positive, your blood type status requires no special medical consideration in everyday life. You’re in the vast majority, and transfusion compatibility is straightforward.
If you’re Rh-negative, the main practical implications are around blood transfusions and pregnancy. You should know your blood type so medical teams can match you correctly, and if you’re pregnant or planning to become pregnant, your provider will check your Rh status early. The preventive treatments available today are highly effective, and serious complications from Rh incompatibility are now uncommon with proper care. If you’re eligible to donate blood, Rh-negative donations are always in demand, particularly O-negative, since it serves as the universal emergency supply.